Apogee Therapeutics (APGE) News Today → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free APGE Stock Alerts $48.62 +1.49 (+3.16%) (As of 03:20 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineJennison Associates LLC Invests $2.90 Million in Apogee Therapeutics, Inc. (NASDAQ:APGE)marketbeat.com - April 27 at 6:08 AMApogee Therapeutics (NASDAQ:APGE) Trading Down 6.2%marketbeat.com - April 24 at 7:14 PMApogee Therapeutics (NASDAQ:APGE) Trading Down 6.1%marketbeat.com - April 18 at 4:55 PMApogee Therapeutics (NASDAQ:APGE) Stock Price Up 3.3%marketbeat.com - April 17 at 11:57 AMWith 54% institutional ownership, Apogee Therapeutics, Inc. (NASDAQ:APGE) is a favorite amongst the big gunsfinance.yahoo.com - April 16 at 10:06 AMApogee Therapeutics, Inc. (APGE)finance.yahoo.com - April 15 at 7:15 PMVanguard Group Inc. Makes New Investment in Apogee Therapeutics, Inc. (NASDAQ:APGE)marketbeat.com - April 14 at 4:16 AMApogee Therapeutics, Inc. (NASDAQ:APGE) Short Interest Updatemarketbeat.com - April 12 at 7:37 AMApogee Therapeutics (NASDAQ:APGE) Trading Up 7%marketbeat.com - April 11 at 4:01 PMApogee Therapeutics, Inc. (NASDAQ:APGE) Receives Average Recommendation of "Buy" from Brokeragesmarketbeat.com - April 9 at 4:10 AMApogee Therapeutics (NASDAQ:APGE) Stock Price Down 3.2%marketbeat.com - April 8 at 2:28 PMApogee Therapeutics (NASDAQ:APGE) Trading Down 9.1%marketbeat.com - April 2 at 5:45 PMKey Proteo Submits De Novo Application to FDA for its First Newborn Screening Kitfinance.yahoo.com - March 29 at 8:15 AMGov. Youngkin vetoes bills that would legalize retail marijuana sales, increase minimum wagemsn.com - March 28 at 10:14 PMUS FDA extends review of Applied Therapeutics' genetic disease drugfinance.yahoo.com - March 28 at 5:11 PMBuy Rating Affirmed for Apogee Therapeutics as APG777 Shows Promise and Pipeline Progressesmarkets.businessinsider.com - March 27 at 10:40 AMApogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseasesglobenewswire.com - March 25 at 7:00 AMTeachers Retirement System of The State of Kentucky Takes $474,000 Position in Apogee Therapeutics, Inc. (NASDAQ:APGE)marketbeat.com - March 22 at 4:35 AMShort Interest in Apogee Therapeutics, Inc. (NASDAQ:APGE) Declines By 5.2%marketbeat.com - March 18 at 1:33 AMApogee Therapeutics, Inc. (NASDAQ:APGE) Given Average Rating of "Buy" by Analystsmarketbeat.com - March 15 at 6:41 AMTop 3 Health Care Stocks That Are Ticking Portfolio Bombsbenzinga.com - March 14 at 9:49 AMApogee Therapeutics (NASDAQ:APGE) Hits New 1-Year High at $71.80marketbeat.com - March 13 at 10:48 AMARM: Everything You Need To Know About The Lock-Up Expiry (Rating Upgrade)seekingalpha.com - March 13 at 2:26 AMApogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Millionfinance.yahoo.com - March 12 at 8:31 PMApogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $483 Millionglobenewswire.com - March 12 at 4:01 PMAdage Capital Partners GP L.L.C. Buys Shares of 375,000 Apogee Therapeutics, Inc. (NASDAQ:APGE)marketbeat.com - March 10 at 6:36 AMApogee Therapeutics stock slides on pricing upsized stock offering to raise $420 millionmsn.com - March 8 at 10:11 AMApogee Therapeutics, Inc.: Apogee Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - March 8 at 12:15 AMApogee Therapeutics, Inc.edition.cnn.com - March 7 at 7:14 PMApogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offeringglobenewswire.com - March 7 at 6:49 PMApogee Therapeutics (NASDAQ:APGE) Sets New 52-Week High Following Analyst Upgrademarketbeat.com - March 7 at 11:28 AMWedbush Equities Analysts Lower Earnings Estimates for Apogee Therapeutics, Inc. (NASDAQ:APGE)marketbeat.com - March 7 at 6:55 AMApogee Therapeutics price target raised by $47 at Guggenheim, here's whyrealmoney.thestreet.com - March 6 at 7:37 PMApogee Therapeutics, Inc. Announces Proposed Underwritten Public Offeringmarkets.businessinsider.com - March 6 at 7:37 PMBuy Rating Endorsed for Apogee Therapeutics Amid Promising APG777 Phase 1 Resultsmarkets.businessinsider.com - March 6 at 7:37 PMWhy Is Atopic Dermatitis-Focused Apogee Therapeutics Stock Trading Higher On Tuesday?msn.com - March 6 at 7:37 PMInsiders Of Apogee Therapeutics Reap Rewards After Their Investment Jumps Another US$74mfinance.yahoo.com - March 6 at 7:37 PMApogee Therapeutics: Success In Phase 1 Bodes Well For Continued APG777 Advancementseekingalpha.com - March 6 at 4:13 PMRA Capital Management L.P. Makes New Investment in Apogee Therapeutics, Inc. (NASDAQ:APGE)marketbeat.com - March 6 at 2:35 PMApogee Therapeutics (NASDAQ:APGE) Given New $75.00 Price Target at Jefferies Financial Groupmarketbeat.com - March 6 at 10:40 AMApogee Therapeutics (NASDAQ:APGE) Trading 6.8% Higher After Analyst Upgrademarketbeat.com - March 6 at 10:20 AMAnalysts Offer Predictions for Apogee Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:APGE)marketbeat.com - March 6 at 8:33 AMAPGE Stock Earnings: Apogee Therapeutics Beats EPS for Q4 2023investorplace.com - March 5 at 11:33 PMApogee Therapeutics, Inc. Announces Proposed Underwritten Public Offeringglobenewswire.com - March 5 at 4:23 PMApogee Therapeutics' Innovative Leap In Atopic Dermatitis Managementseekingalpha.com - March 5 at 1:28 PMApogee Therapeutics (NASDAQ:APGE) Shares Gap Up to $41.74marketbeat.com - March 5 at 12:42 PMApogee Therapeutics (NASDAQ:APGE) Receives "Outperform" Rating from Wedbushmarketbeat.com - March 5 at 11:43 AMApogee Therapeutics Shares Gain on Promising Dermatitis Drug Trialmarketwatch.com - March 5 at 9:58 AMApogee Therapeutics Reports Positive Data From Phase 1 Study Of APG777markets.businessinsider.com - March 5 at 9:58 AMIPO Stock Apogee Rockets On Solid Phase 1 Outcomefinance.yahoo.com - March 5 at 9:58 AM Get Apogee Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Have You Seen Elon’s New A.I. Device? (Picture Inside) (Ad)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast... This strange new device to protect us against that A.I. threat... APGE Media Mentions By Week APGE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APGE News Sentiment▼0.770.34▲Average Medical News Sentiment APGE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APGE Articles This Week▼22▲APGE Articles Average Week Get Apogee Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACLX News Today IMCR News Today CGON News Today VCEL News Today DNLI News Today SWTX News Today KYMR News Today IBRX News Today SANA News Today RXRX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APGE) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apogee Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
